X @The Wall Street Journal
The Wall Street Journal·2026-01-25 19:32
The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion. https://t.co/CT338S45B4 ...
The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion. https://t.co/CT338S45B4 ...